XU Ying. Efficacy and safety of escitalopram versus escitalopram plus dutoxetine in treatment of patients with post-schizophrenia depression: a case-control study[J]. Journal of Clinical Medicine in Practice, 2017, (23): 18-20. DOI: 10.7619/jcmp.201723006
|
Citation:
|
XU Ying. Efficacy and safety of escitalopram versus escitalopram plus dutoxetine in treatment of patients with post-schizophrenia depression: a case-control study[J]. Journal of Clinical Medicine in Practice, 2017, (23): 18-20. DOI: 10.7619/jcmp.201723006
|
XU Ying. Efficacy and safety of escitalopram versus escitalopram plus dutoxetine in treatment of patients with post-schizophrenia depression: a case-control study[J]. Journal of Clinical Medicine in Practice, 2017, (23): 18-20. DOI: 10.7619/jcmp.201723006
|
Citation:
|
XU Ying. Efficacy and safety of escitalopram versus escitalopram plus dutoxetine in treatment of patients with post-schizophrenia depression: a case-control study[J]. Journal of Clinical Medicine in Practice, 2017, (23): 18-20. DOI: 10.7619/jcmp.201723006
|
DownLoad: